Floatz logo

1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)

Prostate Cancer

AstraZenecaSmall moleculePhase 3Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
59/ 100

Competitive context

426 Active assets in the Prostate Cancer cohort.

Asset / SponsorPhaseRating
Degarelix
Bayer
Phase 4BBB
AVOLVE
Masonic Cancer Center, University of Minnesota
Phase 4BB
Flotufolastat F-18
Washington University School of Medicine
Phase 4BB
Estramustine
The University of Texas Health Science Center, Houston
Phase 3BB
PREDNISONE TABLETS
Mayo Clinic
Phase 4BB

View all 50 →

Same molecule, other indications

1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1) is also rated in:

Metastatic Castration-Sensitive Prostate CancerDormant
B
Indicative ·
60 / 100
View asset →
Endoscopic Variceal Band LigationDormant
B
Indicative ·
60 / 100
View asset →
gastroesophageal reflux diseaseDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →